CN113318180A - 一种治疗跌打损伤的中药组合物及其制备方法 - Google Patents
一种治疗跌打损伤的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN113318180A CN113318180A CN202110831917.6A CN202110831917A CN113318180A CN 113318180 A CN113318180 A CN 113318180A CN 202110831917 A CN202110831917 A CN 202110831917A CN 113318180 A CN113318180 A CN 113318180A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traumatic injury
- blood
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014674 injury Diseases 0.000 title claims abstract description 45
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 53
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 22
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 22
- 239000004863 Frankincense Substances 0.000 claims abstract description 20
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 16
- 241000903946 Clematidis Species 0.000 claims abstract description 16
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 15
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 15
- 241000208688 Eucommia Species 0.000 claims abstract description 14
- 241000123866 Homalomena occulta Species 0.000 claims abstract description 7
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 5
- 241001057584 Myrrha Species 0.000 claims abstract description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 4
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims description 32
- 239000008159 sesame oil Substances 0.000 claims description 18
- 235000011803 sesame oil Nutrition 0.000 claims description 18
- 240000007551 Boswellia serrata Species 0.000 claims description 17
- 229920000742 Cotton Polymers 0.000 claims description 17
- 239000004744 fabric Substances 0.000 claims description 17
- 241000382455 Angelica sinensis Species 0.000 claims description 16
- 240000007311 Commiphora myrrha Species 0.000 claims description 16
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 16
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 15
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 15
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 15
- 244000235603 Acacia catechu Species 0.000 claims description 14
- 241000123589 Dipsacus Species 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 241000725145 Homalomena Species 0.000 claims description 12
- 241000112528 Ligusticum striatum Species 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 240000004824 Trimezia steyermarkii Species 0.000 claims description 11
- 239000009136 dragon's blood Substances 0.000 claims description 11
- 244000131316 Panax pseudoginseng Species 0.000 claims description 10
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 244000237330 gutta percha tree Species 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 241000132012 Atractylodes Species 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 3
- 241000173529 Aconitum napellus Species 0.000 claims description 2
- 239000009286 sanguis draxonis Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 65
- 210000004369 blood Anatomy 0.000 abstract description 39
- 239000008280 blood Substances 0.000 abstract description 39
- 208000002193 Pain Diseases 0.000 abstract description 37
- 230000036407 pain Effects 0.000 abstract description 37
- 230000001737 promoting effect Effects 0.000 abstract description 31
- 230000017531 blood circulation Effects 0.000 abstract description 17
- 241000227129 Aconitum Species 0.000 abstract description 10
- 230000003213 activating effect Effects 0.000 abstract description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 244000061520 Angelica archangelica Species 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 241000239226 Scorpiones Species 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000080767 Areca catechu Species 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 23
- 210000003734 kidney Anatomy 0.000 description 21
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 13
- 206010042674 Swelling Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 230000006378 damage Effects 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 239000000341 volatile oil Substances 0.000 description 11
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- XDROKJSWHURZGO-UHFFFAOYSA-N angelicin Chemical compound C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- -1 ligustrazine) Chemical class 0.000 description 8
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 8
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 7
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 7
- 229940039750 aconitine Drugs 0.000 description 7
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 235000019633 pungent taste Nutrition 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 210000002460 smooth muscle Anatomy 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 241000218158 Clematis Species 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 241001446509 Psoralea Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- RNYZJZKPGHQTJR-UHFFFAOYSA-N protoanemonin Chemical compound C=C1OC(=O)C=C1 RNYZJZKPGHQTJR-UHFFFAOYSA-N 0.000 description 4
- MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 4
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010000242 Abortion threatened Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 240000000031 Achyranthes bidentata Species 0.000 description 3
- 241000345998 Calamus manan Species 0.000 description 3
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 239000005770 Eugenol Substances 0.000 description 3
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000218164 Menispermaceae Species 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010061876 Obstruction Diseases 0.000 description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 3
- 241000218201 Ranunculaceae Species 0.000 description 3
- 206010061363 Skeletal injury Diseases 0.000 description 3
- 241000913745 Spatholobus Species 0.000 description 3
- 241001369613 Stephania tetrandra Species 0.000 description 3
- 208000005985 Threatened Abortion Diseases 0.000 description 3
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229960002217 eugenol Drugs 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- GQRPJUIKGLHLLN-VSTHTWNCSA-N mesaconine Chemical compound COC[C@]12CN(C)C3[C@@H]4[C@H](OC)[C@H]1[C@]3([C@@H]1C[C@@]3(O)[C@H](O)[C@@H]1[C@]4(O)[C@@H](O)[C@@H]3OC)[C@H](C[C@H]2O)OC GQRPJUIKGLHLLN-VSTHTWNCSA-N 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 2
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 2
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 241001671653 Aconitum carmichaelii Species 0.000 description 2
- 241000219317 Amaranthaceae Species 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000092665 Atractylodes macrocephala Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 2
- 241000208229 Burseraceae Species 0.000 description 2
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 244000241463 Cullen corylifolium Species 0.000 description 2
- 241000514824 Cyathula officinalis Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 206010049077 Hernia pain Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 2
- UWEHVAXMSWXKRW-UHFFFAOYSA-N Sinactine Chemical compound C1C2=C3OCOC3=CC=C2CC2N1CCC1=C2C=C(OC)C(OC)=C1 UWEHVAXMSWXKRW-UHFFFAOYSA-N 0.000 description 2
- 241001643409 Sinomenium acutum Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 206010049514 Traumatic fracture Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 description 2
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 2
- 229940117895 bakuchiol Drugs 0.000 description 2
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- 229930006722 beta-pinene Natural products 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- YGJXLMNSTLJAMX-WCZGGOQOSA-N ctk4h2880 Chemical compound C([C@]1([H])[C@@]2([H])C[C@@]3([H])[C@@]4([H])NC1)CC[C@]42[C@@H]1C[C@@]2([H])C[C@]1([H])[C@@H]3CC2 YGJXLMNSTLJAMX-WCZGGOQOSA-N 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- PHASMOUKYDUAOZ-IXLJIIPOSA-N deoxyaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6(COC)CN(C5[C@H]([C@H](OC)[C@H]64)[C@](OC(C)=O)([C@H]31)[C@@H](O)[C@@H]2OC)CC)C(=O)C1=CC=CC=C1 PHASMOUKYDUAOZ-IXLJIIPOSA-N 0.000 description 2
- PHASMOUKYDUAOZ-UHFFFAOYSA-N deoxyaconitine Natural products C12C(OC(C)=O)(C(O)C3OC)C(C(OC)C45)C6N(CC)CC4(COC)CCC(OC)C56C2CC3(O)C1OC(=O)C1=CC=CC=C1 PHASMOUKYDUAOZ-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000009207 exercise therapy Methods 0.000 description 2
- IIQSJHUEZBTSAT-VMPREFPWSA-N fangchinoline Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-VMPREFPWSA-N 0.000 description 2
- IIQSJHUEZBTSAT-UHFFFAOYSA-N fangchinoline Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-UHFFFAOYSA-N 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- GGHMUJBZYLPWFD-UHFFFAOYSA-N patchoulialcohol Chemical compound C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000001020 rhythmical effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 150000008130 triterpenoid saponins Chemical class 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- ZJSJQWDXAYNLNS-UHFFFAOYSA-N (+) pinoresinol-4,4'-di-O-beta-D-glucopyranoside Natural products COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(OC4C(C(O)C(O)C(CO)O4)O)=CC=3)CO2)=CC=C1OC1OC(CO)C(O)C(O)C1O ZJSJQWDXAYNLNS-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- ALFVETOFBDLGLQ-MRXNPFEDSA-N (+)-Sinactine Natural products O(C)c1c(OC)cc2c([C@@H]3[N+](Cc4c5OCOc5ccc4C3)CC2)c1 ALFVETOFBDLGLQ-MRXNPFEDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- LFJQCDVYDGGFCH-JTQLQIEISA-N (+)-β-phellandrene Chemical compound CC(C)[C@@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-JTQLQIEISA-N 0.000 description 1
- LFJQCDVYDGGFCH-SNVBAGLBSA-N (+/-)-beta-Phellandrene Natural products CC(C)[C@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-SNVBAGLBSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- NWBWCXBPKTTZNQ-UHFFFAOYSA-N (16S)-4-(N-Acetyl-anthraniloyloxy)-20-aethyl-1alpha,14alpha,16-trimethoxy-aconitan-8,9-diol Natural products C1CC(OC)C2(C3C4)C5CC(C(C6)OC)C(OC)C5(O)C6(O)C4C2N(CC)CC31OC(=O)C1=CC=CC=C1NC(C)=O NWBWCXBPKTTZNQ-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- ZJSJQWDXAYNLNS-FUPWJLLWSA-N (2s,3r,4s,5s,6r)-2-[4-[(3s,3ar,6s,6ar)-6-[3-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound COC1=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)CO2)=CC=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZJSJQWDXAYNLNS-FUPWJLLWSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- RUJPNZNXGCHGID-UHFFFAOYSA-N (Z)-beta-Terpineol Natural products CC(=C)C1CCC(C)(O)CC1 RUJPNZNXGCHGID-UHFFFAOYSA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- SWWQQSDRUYSMAR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride Chemical group Cl.C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 SWWQQSDRUYSMAR-UHFFFAOYSA-N 0.000 description 1
- INYYVPJSBIVGPH-UHFFFAOYSA-N 14-episinomenine Natural products C1CN(C)C2CC3=CC=C(OC)C(O)=C3C31C2C=C(OC)C(=O)C3 INYYVPJSBIVGPH-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 1
- HVDFMKSCPKILEQ-UHFFFAOYSA-N 5-methoxy-2,3-dimethylphenol Chemical compound COC1=CC(C)=C(C)C(O)=C1 HVDFMKSCPKILEQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 241000701413 Aconitum kusnezoffii Species 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- JLUQTCXCAFSSLD-NXEZZACHSA-N Anemonin Chemical compound C1=CC(=O)O[C@]11[C@@]2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-NXEZZACHSA-N 0.000 description 1
- JLUQTCXCAFSSLD-UHFFFAOYSA-N Anemonin Natural products C1=CC(=O)OC11C2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-UHFFFAOYSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- DFOCUWZXJBAUSQ-URLMMPGGSA-N Berbamine Chemical compound C([C@@H]1N(C)CCC=2C=C(C(OC=3C(OC)=C(OC)C=C4CCN(C)[C@@H](C=34)CC=3C=C(C(=CC=3)O)O3)=CC=21)OC)C1=CC=C3C=C1 DFOCUWZXJBAUSQ-URLMMPGGSA-N 0.000 description 1
- DFOCUWZXJBAUSQ-UHFFFAOYSA-N Berbamine Natural products O1C(C(=CC=2)O)=CC=2CC(C=23)N(C)CCC3=CC(OC)=C(OC)C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C1C=C2 DFOCUWZXJBAUSQ-UHFFFAOYSA-N 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 206010006272 Breast mass Diseases 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000601157 Clematis angustifolia Species 0.000 description 1
- 241001256368 Clematis chinensis Species 0.000 description 1
- 241000915582 Clematis manshurica Species 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 208000000860 Compassion Fatigue Diseases 0.000 description 1
- 206010010214 Compression fracture Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000241550 Cyathula Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 241000729170 Dipsacus asper Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 240000002373 Ficus pumila Species 0.000 description 1
- 235000006718 Ficus pumila Nutrition 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000134874 Geraniales Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025327 Lymphopenia Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000270711 Malaclemys terrapin Species 0.000 description 1
- 241000245050 Menispermum Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- GGHMUJBZYLPWFD-MYYUVRNCSA-N Patchouli alcohol Natural products O[C@@]12C(C)(C)[C@H]3C[C@H]([C@H](C)CC1)[C@]2(C)CC3 GGHMUJBZYLPWFD-MYYUVRNCSA-N 0.000 description 1
- 206010034238 Pelvic adhesions Diseases 0.000 description 1
- 206010034246 Pelvic fractures Diseases 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000206469 Pulsatilla Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- INYYVPJSBIVGPH-QHRIQVFBSA-N Sinomenine Chemical compound C([C@@H]1N(CC2)C)C3=CC=C(OC)C(O)=C3[C@@]32[C@@H]1C=C(OC)C(=O)C3 INYYVPJSBIVGPH-QHRIQVFBSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001330502 Stephania Species 0.000 description 1
- 240000007267 Stephania hernandifolia Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- PULWZCUZNRVAHT-LOCDBSKESA-N benzoylmesaconine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 PULWZCUZNRVAHT-LOCDBSKESA-N 0.000 description 1
- PULWZCUZNRVAHT-UHFFFAOYSA-N benzoylmesaconine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 PULWZCUZNRVAHT-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- LFJQCDVYDGGFCH-UHFFFAOYSA-N beta-phellandrene Natural products CC(C)C1CCC(=C)C=C1 LFJQCDVYDGGFCH-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- RARWEROUOQPTCJ-RBUKOAKNSA-N cepharamine Natural products C1CC2=CC=C(OC)C(O)=C2[C@@]2(CCN3C)[C@]13C=C(OC)C(=O)C2 RARWEROUOQPTCJ-RBUKOAKNSA-N 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000000001 effect on platelet aggregation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000000095 emetic effect Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 231100001023 lymphopenia Toxicity 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000011224 negative regulation of urine volume Effects 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000005830 nonesterified fatty acids Chemical class 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 229930194301 safflor yellow Natural products 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229930002966 sinomenine Natural products 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- UEAPAHNNFSZHMW-UHFFFAOYSA-N stepahnine Natural products COC1=CC=CC(C2=C34)=C1CC3N(C)CCC4=CC1=C2OCO1 UEAPAHNNFSZHMW-UHFFFAOYSA-N 0.000 description 1
- UEAPAHNNFSZHMW-CQSZACIVSA-N stephanine Chemical compound CN([C@@H]1CC2=C(C3=C11)C=CC=C2OC)CCC1=CC1=C3OCO1 UEAPAHNNFSZHMW-CQSZACIVSA-N 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004926 tubular epithelial cell Anatomy 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- NWBWCXBPKTTZNQ-QOQRDJBUSA-N y4m5974f7z Chemical compound O([C@]12CN([C@@H]3[C@H]4[C@]5(O)[C@@]6(O)[C@@H](OC)[C@@H]([C@H](C5)OC)C[C@H]6[C@@]3([C@@H]1C4)[C@@H](OC)CC2)CC)C(=O)C1=CC=CC=C1N=C(C)O NWBWCXBPKTTZNQ-QOQRDJBUSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中草药技术领域,公开了一种治疗跌打损伤的中药组合物及其制备方法。该组合物是以当归和川芎作为君药,用于补血,活血,行气止痛;以鸡血藤,乳香,没药,白术,川断,补骨脂,三七,牛膝,威灵仙为臣药,用于活血化湿,益精补髓;以川乌,草乌,忍冬藤,千年健,防己,杜仲,青凤藤,红花,血蝎,儿茶为佐使药,上述药物君臣佐使协同作用,具有良好的活血化瘀,通络止痛,散结之功效,进而达到治疗跌打损伤的目的。该组合物的成品为黑色膏药剂,具有良好的活血化瘀,通络止痛作用,无任何毒副作用,具有极强的安全性和有效性。
Description
技术领域
本发明属于中草药技术领域,具体涉及一种治疗跌打损伤的中药组合物及其制备方法。
背景技术
跌打损伤在日常生活中对于有些人似乎是家常便饭,泛指人因跌、打、碰、磕等原因所致的软组织损伤,以肿胀、疼痛为主要表现。当存在上述问题的患者出现时,身体的痛感会让患者急于诊治,此时很多人会使用药物熏洗的方式进行治疗。药物熏洗的方式多是适用于患者机体内循环方面,对于部分由于碰撞进而导致出现严重的跌打损伤病症或是骨折时,该种方法不但没有疗效,而且病情会越来越严重。
中医治疗跌打损伤有着几千年的历史,古称“跌打损伤”为诸伤之总论,多因外力作用,或自身姿势不正确的情况下用力过猛而造成的。中医把凡因外力作用于人体而引起的筋骨伤损、瘀血肿痛、气血不和、经络不通以至脏器受损等,统称为跌打损伤。
现有的一些跌打损伤配方在治疗过程中,仍旧存在药物药效不强,伤口恶疮痈疽,久不收口,金疮出血,创口不合等问题。甚至存在一定的副作用,易对患者造成身体二次创伤。
发明内容
为了解决现有技术存在的上述问题,本发明目的在于提供一种治疗跌打损伤的中药组合物及其制备方法。
本发明所采用的技术方案为:一种治疗跌打损伤的中药组合物,所述组合物主要由以下质量份数的原料制备得到:
当归100-200份,川芎100-200份,忍冬藤50-100份,川乌50-100份,草乌50-100份,威灵仙100-200份,鸡血藤100-200份,千年健60-120份,防己50-100份,杜仲90-220份,乳香60-120份,没药60-120份,补骨脂60-120份,川断90-220份,白术100-200份,青风藤100-200份,红花20-40份,三七60-120份,血竭30-70份,儿茶60-120份和牛膝60-120份。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
当归110-180份,川芎110-180份,忍冬藤60-90份,川乌60-90份,草乌60-90份,威灵仙110-180份,鸡血藤110-180份,千年健70-100份,防己60-90份,杜仲110-200份,乳香70-100份,没药70-100份,补骨脂70-100份,川断110-200份,白术110-180份,青风藤110-180份,红花22-36份,三七70-100份,血竭35-50份,儿茶70-100份和牛膝70-100份。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
当归160份,川芎160份,忍冬藤80份,川乌80份,草乌80份,威灵仙160份,鸡血藤160份,千年健85份,防己80份,杜仲130份,乳香85份,没药85份,补骨脂85份,川断128份,白术160份,青风藤160份,红花32份,三七85份,血竭42份,儿茶85份和牛膝85份。
当归,中药名。为伞形科当归属植物当归Angelica sinensis(Oliv)Diels.的根。具有补血调经,活血止痛,润肠通便的功效。主治血虚萎黄,月经不调,经闭痛经,血虚、血滞、血寒诸痛,跌打损伤,风湿痹痛,痈疽疮疡,肠燥便秘等。味甘、辛,性温;归肝、心经。当归中含β-蒎烯、α-蒎烯、莰烯等中性油成分。含对-甲基苯甲醇、5-甲氧基-2,3-二甲苯酚等酸性油成分、有机酸、糖类、维生素、氨基酸等。当归毒性小,小鼠静脉注射当归的LD50为80-100g/kg;挥发油皮下注射和灌胃LD50分别为298mg/kg和96mg/kg。
川芎,中药名,为伞形科藁本属植物川芎Ligusticum chuanxiong Hort.的干燥根茎。具有活血行气,祛风止痛的功效。主要用于心脉瘀阻之胸痹心痛、肝郁气滞之胁肋胀痛、肝血瘀阻之胸胁刺痛、瘀血阻滞之跌仆损伤、疮疡肿痛、月经不调、经闭痛经、产后瘀痛、恶露不行、多种头痛和风湿痹痛等。味辛,性温;归肝、胆、心包经。本品含生物碱(如川芎嗪),挥发油(主要为藁本内脂、香烩烯等),酚类物质(如阿魏酸),内脂素以及维生素A、叶酸、蔗糖、甾醇、脂肪油等。小鼠静注川芎嗪的LD50为239m/kg。
忍冬藤,中药名。又名大薜荔、水杨藤、千金藤,多年生半常绿缠绕灌木,茎中空,幼枝密生短柔毛。具有清热解毒,疏风通络的疗效。可用于温病发热,疮痈肿毒,热毒血痢,风湿热痹,关节红肿热痛。甘,寒。归肺、胃经。本草纲目》:“忍冬茎叶及花功用皆同。昔人称其治风、除胀、解痢为要药,而后世不复知用:后世称其消肿、散毒、治疮为要药,而昔人并未言及,乃知古今之理,万变不同,未可一辙论也。按陈自明《外科精要》云,忍冬酒治痈疽发背,初发便当服此,其效甚奇,胜于红内消。洪迈、沈括诸方所载甚详。”
川乌,中药名。为毛茛科乌头属植物乌头Aconitum carmichaelii Debx.的干燥母根。具有祛风除湿,温经,散寒止痛的功效。主治风寒湿痹,关节疼痛,肢体麻木,半身不遂,头风头痛,心腹冷痛,寒疝作痛,跌打瘀痛,阴疽肿毒。并可用于麻醉止痛。味辛、苦,性热;归心、肝、脾经。块根(母根)含乌头碱、次乌头碱、中乌头碱、塔拉胺、消旋去甲基衡州乌药碱、异塔拉定、新乌宁碱、准噶尔乌头碱、附子宁碱、去甲猪毛菜碱、异飞燕草碱、苯甲酰中乌头碱、多根乌头碱、森布星A、森布星B、14-乙酰塔拉胺、脂乌头碱、脂次乌头碱、脂去氧乌头碱、脂中乌头碱、北草乌碱、川附宁、3-去氧乌头碱、惰碱、荷克布星A及B、尿嘧啶、乌头多糖A、B、C、D。生川乌煎剂小鼠灌服的LD50为18.0±0.034g/kg。
草乌,中药名。为毛茛科乌头属植物北乌头Aconitum kusnezoffii Reichb.的干燥块根。具有祛风除湿,温经止痛的功效。主要用于用于风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛及麻醉止痛。味辛、苦,性热;归心、肝、肾经。主含多种生物碱:如乌头碱、次乌头碱、中乌头碱、消旋去甲乌头碱酯乌头碱、酯次乌头碱、酯中乌头碱、3-去氧乌头碱、多根乌头碱、新乌宁碱、川附宁、附子宁碱、森布宁A、森布宁B、北草乌碱、惰碱、塔拉胺、异塔拉定,以及乌头多糖A、B、C、D等。
威灵仙,中药名。为毛茛科铁线莲属植物威灵仙Clematis chinensis Osbeck、棉团铁线莲Clematis hexapetala Pall.或东北铁线莲Clematis manshurica Rupr.的干燥根和根茎。具有祛风湿,通络止痛,消骨鲠的功效。主治风湿痹证、骨鲤咽喉、跌打伤痛、头痛、牙痛、胃脘痛,及痰饮、噎膈、妇女癥瘕积块、乳房肿块等。味辛、咸,性温;归膀胱经。本品含原白头翁素,白头翁内酯,甾醇,糖类,皂苷等。1、对心血管系统的影响:对抗心肌缺血、降低血压。2、对消化系统的影响:促进胆汁分泌,松弛总胆管末端括约肌,松弛回肠平滑肌,增强食管平滑肌蠕动。3、对泌尿系统的影响:抗利尿,增加尿酸盐排泄。4、抗病原微生物作用:对革兰阳性及阴性菌和真菌都有较强的抑制作用,并抑制疟原虫。5、此外,威灵仙还有一定的镇痛、解热、降血糖、抗肿瘤、引产、对皮肤刺激作用等。原白头翁素具刺激性,接触过久可使皮肤发泡,粘膜充血,原白头翁素易聚合成白头翁素,白头翁素为威灵仙有成分,服用过量可引起中毒。
鸡血藤,中药名。为豆科密花豆属植物密花豆Spatholobus suberectus Dunn的干燥藤茎。具有行血补血,调经,舒筋活络的功效。主治月经不调,痛经,闭经,风湿痹痛,手足麻木,肢体瘫痪,血虚萎黄。味苦、微甘,性温;归肝、肾经。主要含有异黄酮类化合物如刺芒柄花素、大豆黄素等,三萜类化合物如表木栓醇、木栓酮等以及甾体类化合物如β-谷甾醇、胡萝卜素苷、油菜甾醇、鸡血藤醇等。水提醇沉制剂能增加实验动物股动脉血流量,降低血管阻力,对血小板聚集有明显抑制作用;水煎剂可降低动物胆固醇,明显对抗动脉粥样硬化病变;水提物及酊剂有明显的抗炎作用,并对免疫系统有双向调节功能;酊剂有一定的镇静催眠作用;注射液或灌胃对小鼠有明显的抗早孕作用;鸡血藤尚能促进小鼠肾总磷代谢,促进小鼠子宫24小时总磷代谢。
千年健,中药名。为天南星科千年健属植物千年健Homalomena occulta(Lour.)Schott的干燥根茎。具有祛风湿,壮筋骨的功效。主治风寒湿痹。味苦、辛,性温;归肝、肾经。本品含挥发油,主要为α-蒎烯、β-蒎烯、柠檬烯、芳樟醇、α-松油醇、β-松油醇、橙花醇、香叶醇、香叶醛、丁香油酚、异龙脑、广藿香醇等。千年健甲醇提取物有明显的抗炎、镇痛作用,醇提液有抗组胺作用,其水提液具有较强的抗凝血作用,所含挥发油对布氏杆菌、I型单纯疱疹病毒有抑制作用。
防己,中药名。为防己科千金藤属植物粉防己Stephania tetrandra S.Moore的干燥根。习称“汉防己”。具有祛风湿,止痛,利水消肿的功效。主治风湿痹证,水肿,小便不利,脚气,湿疹疮毒。味苦、辛,性寒;归膀胱、肺经。汉防己(粉防己)含粉防己碱(即汉防己甲素),防己诺灵碱,轮环藤酚碱,氧防己碱,防己斯任碱,小檗胺,2,2’-N,N-二氯甲基粉防己碱,粉防己碱A、B、C、D。粉防己能明显增加排尿量。总碱及流浸膏或煎剂有镇痛作用。粉防己碱有抗炎作用;对心肌有保护作用,能扩张冠状血管,增加冠脉流量,有显著降压作用,能对抗心律失常;能明显抑制血小板聚集,还能促进纤维蛋白溶解,抑制凝血酶引起的血液凝固过程;对实验性矽肺有预防治疗作用;对子宫收缩有明显的松弛作用;低浓度的粉防己碱可使肠张力增加,节律性收缩加强,高浓度则降低张力、减弱节律性收缩;有抗菌和抗阿米巴原虫的作用;可使正常大鼠血糖明显降低,血清胰岛素明显升高;有一定抗肿瘤作用;对免疫有抑制作用;有广泛的抗过敏作用。家兔粉防己碱15mg/kg静脉给药后,平均动脉压(MAP)立即急剧下降,心率明显碱慢,心电图出现异常改变。多数家兔出现抽搐,心脏停搏,继而呼吸停止而死亡。高剂量(45mg/kg以上)静脉给药后,小鼠迅速出现兴奋、惊厥而死亡。剂量减少(35mg/kg以下),小鼠兴奋后安静,活动减少,伏而不动。部分小鼠四肢抽搐,呼吸困难,惊厥而死亡,或缓解存活,粉防己碱小鼠静注LD50为37.5±3.6mg/kg。
杜仲,中药名。为杜仲科杜仲属植物杜仲Eucommia ulmoides Oliv.的树皮。具有补肝肾,强筋骨,安胎的功效。主治肾虚腰痛及各种腰痛,胎动不安,习惯性堕胎。味甘,性温;归肝、肾经。本品含杜仲胶、杜仲苷、松脂醇二葡萄糖苷、桃叶珊瑚苷、鞣质、黄酮类化合物等。小鼠灌服生杜仲或盐杜仲煎剂120g/kg,观察7d,无死亡。小鼠腹腔注射杜仲煎剂LD50为17.30±0.52g/kg。大鼠灌服杜仲皮煎剂或醇提取液3.5g/kg,每日1次,连续21d,未发现任何异常(包括体重、血常规、肝功能和肝肾切片镜检)。
乳香,中药名。为橄榄科乳香属植物乳香树Boswellia carterii Birdw.及同属植物树皮渗出的树脂。具有活血行气止痛,消肿生肌的功效。主治活血行气止痛,消肿生肌,气滞血瘀痛。味辛、苦,性温;归心、肝、脾经。主要含有树脂、树胶和挥发油。树脂的主要成分为游离α、β-乳香酸,结合乳香酸,乳香树脂烃;树胶主要成分为阿糖酸的钙盐和镁盐,西黄芪胶黏素;挥发油含蒎稀,α、β-水芹烯等。乳香有镇痛、消炎、升高白细胞的作用,并能加速炎症渗出排泄,促进伤口愈合;所含蒎烯有祛痰作用;乳香能明显减轻阿司匹林、保泰松、利血平所致胃黏膜损伤及应激性黏膜损伤,减低幽门结扎性溃疡指数及胃液游离酸度。
没药,中药名。为橄榄科没药属植物没药树Commiphora myrrha Engl.或其他同属植物皮部渗出的油胶树脂。具有活血止痛,消肿生肌的功效。主治瘀血阻滞所致的跌打损伤,瘀滞肿痛、痈疽肿痛、疮疡溃后久不收口,胸痛、胁痛、心腹痛、痛经、产后腹痛、风湿痹痛,癥瘕积聚等。味辛、苦,性平;归心、肝、脾经。含没药树脂、挥发油(丁香酚等)、树胶、少量苦味质,并含没药酸、甲酸、乙酸及氧化酶等。1、对代谢系统的影响:有降脂、防止动脉内膜粥样斑块形成的作用。2、对子宫的影响:没药对离体子宫先呈短暂的兴奋,使子宫张力提高,收缩频率增加,后呈抑制现象。3、抗病原微生物作用:水浸剂对堇色毛癣菌、同心性毛癣菌、许兰氏黄癣菌等多种致病真菌有抑制作用,挥发油能轻度抑制霉菌。4、此外,没药尚有局部刺激作用,能兴奋肠蠕动。
补骨脂,中药名。为豆科补骨脂属植物补骨脂Psoralea corylifolia L.的成熟果实。具有补肾壮阳,固精缩尿,温脾止泻,纳气平喘的功效。主治肾虚阳痿、腰膝冷痛,肾虚遗精、遗尿、尿频,脾肾阳虚、五更泄泻,肾不纳气,虚寒喘咳。味苦、辛,性温;归肾、脾经。含香豆素类、黄酮类及单萜酚类。复方补骨脂冲剂对垂体后叶素引起的小鼠急性心肌缺血有明显的保护作用,补骨脂对由组胺引起的气管收缩有明显扩张作用,补骨脂酚有雌激素样作用,能增强阴道角化,增强子宫重量,补骨脂是通过调节神经和血液系统,促进骨髓造血,增强免疫和内分泌功能,从而发挥抗衰老作用。补骨脂酚、异补骨脂素及补骨脂总油(醚提物中分得)给小鼠灌胃的LD50分别为2.3±0.18ml/kg、180±29.6mg/kg及38.0±3.5g(生药)/kg;异补骨脂素小鼠腹腔注射的LD50为138.0±10.9mg/kg,小鼠分别灌服补骨脂酚0.125-1.0ml/kg连续1-4星期,均可引起肾脏病变,1.0ml/kg,可引起进行性肾损害,但其他脏器无损伤。补骨脂酚对小鼠进行重复给药的毒性试验,给药28d,均能见到肾脏损害,而其他脏器未见形态学上改变。停药28d后,肾脏损害仍未见好转,故认为补骨脂酚对肾脏有一定毒性。异补骨脂素给小鼠或犬多次灌服(0.2g/kg3d或0.1g/kg2星期)未见有肝肾功能、心电图及脏器病理形态损伤。异补骨脂查尔酮每日以0.1g/kg给大鼠灌胃,连续1个月,对血压、心电图、血象、肝功能及血糖等,均无明显影响。大剂量补骨脂素类加紫外光照射能引起小鼠轻微的肝脏、生殖器、肾上腺皮质的脂肪样变、睾丸萎缩,并致小鼠体重减轻。
川断,中药名。为川续断科川续断属植物川续断Dipsacus asper Wall.ex Henry的干燥根。具有补益肝肾,续筋健骨,通利血脉的功效。主治肝肾不足,腰膝酸痛,寒湿痹痛,崩漏下血,胎动不安,跌打损伤,筋骨折伤等。味苦、甘、辛,性微温;归肝、肾经。本品主要成分为含三萜皂苷类、挥发油。1、对生殖系统的影响:川续断DA303具有抑制子宫肌收缩的作用。2、抗病原微生物的作用:对肺炎链球菌等有抑制作用,并能杀灭阴道毛滴虫。3、止血,镇痛的作用:对痈疡有排脓、止血、镇痛、促进组织再生的作用。4、促进骨损伤愈合的作用:水煎液对骨损伤愈合有促进作用,且随剂量增加作用增强,总皂苷是其促进骨损伤愈合作用的活性成分。5、此外,续断还有抗维生素E缺乏症的作用。
白术,中药名。为菊科苍术属植物白术Atractylodes macrocephala Koidz、的根茎。具有补气健脾,燥湿利水,止汗,安胎的功效。主治脾气虚弱,脾虚积滞,脾虚饮停,痰饮,肌表不固而汗多以及胎动不安。味苦、甘,性温;归脾、胃经。白术含挥发油,油中主要成分为苍术酮,白术内酯A、B及糖类(主要为甘露糖、果糖)等。白术水煎液能促进小鼠胃排空及小肠推进功能,并能防治实验性胃溃疡。白术内酯Ⅰ具有增强唾液淀粉酶活性、促进营养物质吸收、调节胃肠道功能的作用。白术水煎液和流浸膏均有明显而持久的利尿作用。白术多糖、白术挥发油能增强细胞免疫功能。白术水煎液具有抗衰老作用。白术醇提物与石油醚提取物能抑制实验动物子宫平滑肌收缩。此外,白术有保肝、利胆、降血糖、抗菌、抗肿瘤、镇静、镇咳、祛痰等作用。白术煎剂小鼠腹腔注射的LD50为13.3g/kg,多数动物于给药后呈暂时兴奋,后遂安静,但对外界刺激仍然敏感,此作用持续数小时。煎剂0.5g/kg灌胃于大鼠,每日1次,给药14d后,发现白细胞中度减少,主要是淋巴细胞减少;这与临床观察颇不一致。给药2个月,出现轻度贫血,有些动物肾小管上皮细胞颗粒变性,但脑、心、肝组织无异常发现。
青风藤,中药名。为防己科防己属植物青藤Sinomenium acuturn(Thunb.)Rehd.etWils.和毛青藤Sinamenium acutum(Thunb.)Rehd.et Wils.var.cinereum Rehd.et Wils.的干燥藤茎。具有祛风湿,通经络,利小便的功效。用于风湿痹痛,关节肿胀,麻痹瘙痒。味苦、辛,性平;肝、脾经。藤茎及根含青风藤碱、青藤碱、尖防己碱、N-去甲尖防己碱、白兰花碱、光千金藤碱、木兰花碱、四氢表小檗碱、异青藤碱、土藤碱、豆甾醇、β-谷甾醇、消旋丁香树脂酚及十六烷酸甲酯等。1、对免疫系统的影响:对非特异性免疫、细胞免疫和体液免疫均有抑制作用。2、对心血管系统的影响:可使心肌收缩力、心率、舒张压、左心室收缩压、心脏指数、外周血管阻力及心输出量显著下降,有抗心肌缺血、保护再灌注损伤的作用,对心律失常有明显拮抗作用。青风藤总碱的降压作用迅速、强大,多次给药不易产生快速耐受性,但青藤碱反复应用易出现快速耐受性。3、此外,青风藤还能抗炎、镇痛、镇静、镇咳,抑制肠平滑肌的收缩,甲醇提取液能使子宫平滑肌收缩力增强、肌张力增高,尚有一定的降温和较弱的催吐作用。
红花,中药名。为菊科红花属植物红花Carthamus tinctorius L.的干燥花。具有活血通经,祛瘀止痛的功效。主治血滞经闭、痛经,产后瘀滞腹痛,癥瘕积聚,胸痹心痛,血瘀腹痛,胁痛,跌打损伤,瘀滞肿痛,瘀滞斑疹色暗。味辛,性温;归心、肝经。含有红花醌苷、新红花苷、红花苷、红花黄色素和黄色素。另含红花油,油中包括棕榈酸、肉豆蔻酸、月桂酸、硬脂酸、花生酸、油酸等。1、对心血管系统的影响:红花轻度兴奋心脏、降低冠脉阻力,增加冠脉流量和心肌营养性血流量,保护和改善心肌缺血,缩小心肌梗死范围;红花黄色素分离物能对抗心律失常;煎剂、水提液、红花黄色素等能扩张周围血管、降低血压。2、对血液流变学的影响:红花能抗凝血,抗血栓形成,降低全血黏度,降低红细胞的聚集性,维持血液黏度的正常。3、对神经系统的影响:红花黄色素对中枢神经系统有镇痛、镇静和抗惊厥作用。注射液、醇提物、红花苷能显著提高耐缺氧能力,减少缺血性脑水肿,对实验性脑梗死动物的组织有保护作用。4、对肝胆系统的影响:红花能降低谷丙转氨酶,改善肝功能。5、对代谢系统的影响:红花能降低血清总胆固醇、三硝酸甘油脂和非酯化脂肪酸水平。6、对生殖器官的影响:红花煎剂对子宫和肠道平滑肌有兴奋作用,抗盆腔粘连。此外,红花醇提物和水提物有抗炎作用,红花黄色素有免疫抑制作用。红花煎剂1g/kg小鼠腹腔注射,无毒性反应。
牛膝,中药名。为苋科牛膝属植物牛膝(怀牛膝)Achyranthes bidentata BI.和川牛膝属(杯苋属)植物川牛膝(甜牛膝)Cyathula officinalis Kuan的根。具有活血通经,补肝肾,强筋骨,利水通淋,引火(血)下行的功效。主治瘀血阻滞经闭、痛经、经行腹痛、胞衣不下,跌打伤痛,腰膝酸痛,下肢痿软,淋证,水肿,小便不利,头痛,眩晕,齿痛,口舌生疮,吐血,衄血。味苦、甘、酸,性平;归肝、肾经。牛膝含有三萜皂苷(经水解后成为齐墩果酸和糖)、蜕皮甾酮、牛膝甾酮、紫茎牛膝甾酮等甾体类成分和多糖类成分。此外,牛膝还含有精氨酸等12种氨基酸以及生物碱类、香豆素类等化合物和铁、铜等微量元素。其LD50为146.49g/kg。
一种治疗跌打损伤的中药组合物的制备方法,包括按照相应比例选取当归、川芎、忍冬藤、川乌、草乌、威灵仙、鸡血藤、千年健、防己、杜仲、乳香、没药、补骨脂、川断、白术、青风藤、红花和牛膝混合并采用棉布包覆封紧后,放入浸泡剂进行浸泡;待浸泡完成后,去除棉布,加热浸泡剂对上述浸泡完成的所有原料进行炸制、捞除药渣、继续熬制,待浸泡剂呈珠状滴落后冷却,加入粉碎后的三七、血竭和儿茶混匀,获得成品。
作为优选地,所述浸泡剂为芝麻油。
作为优选地,所述选取当归、川芎、忍冬藤、川乌、草乌、威灵仙、鸡血藤、千年健、防己、杜仲、乳香、没药、补骨脂、川断、白术、青风藤、红花和牛膝混合并采用棉布包覆封紧后,放入浸泡剂进行浸泡时长为7-8天。
作为优选地,加热浸泡剂时,加热温度为200-220摄氏度;
所述炸制时长为2-5分钟。
作为优选地,所述继续熬制时温度为80-100摄氏度。
作为优选地,所述冷却至60-70摄氏度。
作为优选地,所述成品为黑色膏药剂。
本发明的有益效果为:
本发明提供了一种治疗跌打损伤的中药组合物,该组合物是以当归和川芎作为君药,用于补血,活血,行气止痛;以鸡血藤,乳香,没药,白术,川断,补骨脂,三七,牛膝,威灵仙为臣药,用于活血化湿,益精补髓;以川乌,草乌,忍冬藤,千年健,防己,杜仲,青凤藤,红花,血蝎,儿茶为佐使药,上述药物君臣佐使协同作用,具有良好的活血化瘀,通络止痛,散结之功效,进而达到治疗跌打损伤的目的。
该组合物的成品为黑色膏药剂,具有良好的活血化瘀,通络止痛作用,无任何毒副作用,具有极强的安全性和有效性。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。本领域技术人员将会理解,下列所描述的实施例是本发明一部分实施例,而不是全部的实施例,仅用于说明本发明,而不应视为限制本发明的范围。所用试剂均为可以通过市售购买获得的常规产品。
实施例1:
一种治疗跌打损伤的中药组合物的制备方法,包括按照相应比例选取当归100克、川芎100克、忍冬藤50克、川乌50克、草乌50克、威灵仙100克、鸡血藤100克、千年健60克、防己50克、杜仲90克、乳香60克、没药60克、补骨脂60克、川断90克、白术100克、青风藤100克、红花20克和牛膝60克混合并采用棉布包覆封紧后,放入芝麻油进行浸泡;待浸泡7天后,去除棉布,加热芝麻油至200摄氏度,对上述浸泡完成的所有原料进行炸制2分钟、捞除药渣、继续在80摄氏度下熬制,待芝麻油呈珠状滴落后冷却至60摄氏度,加入粉碎后的三七60克、血竭30克和儿茶60克混匀,获得黑色膏剂成品。
实施例2:
一种治疗跌打损伤的中药组合物的制备方法,包括按照相应比例选取当归200克、川芎200克、忍冬藤100克、川乌100克、草乌100克、威灵仙200克、鸡血藤200克、千年健120克、防己100克、杜仲220克、乳香120克、没药120克、补骨脂120克、川断220克、白术200克、青风藤200克、红花40克和牛膝120克混合并采用棉布包覆封紧后,放入芝麻油克进行浸泡;待浸泡8天后,去除棉布,加热芝麻油至220摄氏度,对上述浸泡完成的所有原料进行炸制5分钟、捞除药渣、继续在100摄氏度下熬制,待芝麻油呈珠状滴落后冷却至70摄氏度,加入粉碎后的三七120克、血竭70克和儿茶120克混匀,获得黑色膏剂成品。
对于上述炸制之后,各原料呈焦黄色时即可完成该步骤的处理,实际时长可根据所处环境及油剂的温度等进行相应的设计。
实施例3:
一种治疗跌打损伤的中药组合物的制备方法,包括按照相应比例选取当归110克、川芎110克、忍冬藤60克、川乌60克、草乌60克、威灵仙110克、鸡血藤110克、千年健70克、防己60克、杜仲110克、乳香70克、没药70克、补骨脂70克、川断110克、白术110克、青风藤110克、红花22克和牛膝70克混合并采用棉布包覆封紧后,放入芝麻油克进行浸泡;待浸泡7天后,去除棉布,加热芝麻油至200摄氏度,对上述浸泡完成的所有原料进行炸制2分钟、捞除药渣、继续在80摄氏度下熬制,待芝麻油呈珠状滴落后冷却至60摄氏度,加入粉碎后的三七70克、血竭35克和儿茶70克混匀,获得黑色膏剂成品。
实施例4:
一种治疗跌打损伤的中药组合物的制备方法,包括按照相应比例选取当归180克、川芎180克、忍冬藤90克、川乌90克、草乌90克、威灵仙180克、鸡血藤180克、千年健100克、防己90克、杜仲200克、乳香100克、没药100克、补骨脂100克、川断200克、白术180克、青风藤180克、红花36克和牛膝100克混合并采用棉布包覆封紧后,放入芝麻油克进行浸泡;待浸泡8天后,去除棉布,加热芝麻油至220摄氏度,对上述浸泡完成的所有原料进行炸制5分钟、捞除药渣、继续在100摄氏度下熬制,待芝麻油呈珠状滴落后冷却至70摄氏度,加入粉碎后的三七100克、血竭50克和儿茶100克混匀,获得黑色膏剂成品。
实施例5:
一种治疗跌打损伤的中药组合物的制备方法,包括按照相应比例选取当归160克、川芎160克、忍冬藤80克、川乌80克、草乌80克、威灵仙160克、鸡血藤160克、千年健85克、防己80克、杜仲130克、乳香85克、没药85克、补骨脂85克、川断128克、白术160克、青风藤160克、红花32克和牛膝85克混合并采用棉布包覆封紧后,放入芝麻油克进行浸泡;待浸泡7天后,去除棉布,加热芝麻油至200摄氏度,对上述浸泡完成的所有原料进行炸制2分钟、捞除药渣、继续在80摄氏度下熬制,待芝麻油呈珠状滴落后冷却至60摄氏度,加入粉碎后的三85七克、血竭42克和儿茶85克混匀,获得黑色膏剂成品。
使用方式:取黑色膏剂适量滩涂在棉布上,敷于患处遇体温自粘,七天后取下膏药,不留渣,过敏的少,假如有点过敏,皮炎平霜外涂即止。
病患病症严重者,可辅助以射频治疗。
用量方式:轻度的使用三周即可;中度的六周就可以愈合好。七天换一次。每一贴上的大约用量是大约七克左右。
临床病例:
患者1:男,57岁。
患病诊断:髌骨骨折,膝关节半月板损伤,膝关节积液。
治疗方法:射频治疗、灸法治疗与上述实施例5制备得到的黑色膏剂配合,热帖敷治疗。
治疗结果:5周后,病症痊愈。
患者2:男,81岁。
患病诊断:胸腰椎压缩性骨折,骨质疏松症。
治疗方法:射频治疗与上述实施例5制备得到的黑色膏剂配合,热帖敷治疗。
治疗结果:10周后,病症痊愈。
患者3:男,52岁。
患病诊断:骨盆骨折。
治疗方法:射频治疗、针刺运动疗法与上述实施例5制备得到的黑色膏剂配合,热帖敷治疗。
治疗结果:8周后,病症痊愈。
患者4:男,5岁。
患病诊断:锁骨骨折。
治疗方法:射频治疗、红外线治疗与上述实施例5制备得到的黑色膏剂配合,热帖敷治疗。
治疗结果:5周后,病症痊愈。
患者5:男,50岁。
患病诊断:足拇指骨折。
治疗方法:射频治疗、针刺运动疗法与上述实施例5制备得到的黑色膏剂配合,热帖敷治疗。
治疗结果:15周后,病症痊愈。
本发明不局限于上述可选的实施方式,任何人在本发明的启示下都可得出其他各种形式的产品,均属于本发明的保护范围。上述具体实施方式不应理解成对本发明的保护范围的限制,本领域的普通技术人员应当理解,在不背离本发明的范围下,可对前述各实施例所记载的技术方案进行修改,或对其中部分或者全部技术特征进行等同替换,与此同时这些修改或者替换,并不会使相应的技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (10)
1.一种治疗跌打损伤的中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
当归100-200份,川芎100-200份,忍冬藤50-100份,川乌50-100份,草乌50-100份,威灵仙100-200份,鸡血藤100-200份,千年健60-120份,防己50-100份,杜仲90-220份,乳香60-120份,没药60-120份,补骨脂60-120份,川断90-220份,白术100-200份,青风藤100-200份,红花20-40份,三七60-120份,血竭30-70份,儿茶60-120份和牛膝60-120份。
2.根据权利要求1所述的一种治疗跌打损伤的中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
当归110-180份,川芎110-180份,忍冬藤60-90份,川乌60-90份,草乌60-90份,威灵仙110-180份,鸡血藤110-180份,千年健70-100份,防己60-90份,杜仲110-200份,乳香70-100份,没药70-100份,补骨脂70-100份,川断110-200份,白术110-180份,青风藤110-180份,红花22-36份,三七70-100份,血竭35-50份,儿茶70-100份和牛膝70-100份。
3.根据权利要求2所述的一种治疗跌打损伤的中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
当归160份,川芎160份,忍冬藤80份,川乌80份,草乌80份,威灵仙160份,鸡血藤160份,千年健85份,防己80份,杜仲130份,乳香85份,没药85份,补骨脂85份,川断128份,白术160份,青风藤160份,红花32份,三七85份,血竭42份,儿茶85份和牛膝85份。
4.根据权利要求1-3任一所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,包括按照相应比例选取当归、川芎、忍冬藤、川乌、草乌、威灵仙、鸡血藤、千年健、防己、杜仲、乳香、没药、补骨脂、川断、白术、青风藤、红花和牛膝混合并采用棉布包覆封紧后,放入浸泡剂进行浸泡;待浸泡完成后,去除棉布,加热浸泡剂对上述浸泡完成的所有原料进行炸制、捞除药渣、继续熬制,待浸泡剂呈珠状滴落后冷却,加入粉碎后的三七、血竭和儿茶混匀,获得成品。
5.根据权利要求4所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,所述浸泡剂为芝麻油。
6.根据权利要求4所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,所述选取当归、川芎、忍冬藤、川乌、草乌、威灵仙、鸡血藤、千年健、防己、杜仲、乳香、没药、补骨脂、川断、白术、青风藤、红花和牛膝混合并采用棉布包覆封紧后,放入浸泡剂进行浸泡时长为7-8天。
7.根据权利要求4所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,加热浸泡剂时,加热温度为200-220摄氏度;
所述炸制时长为2-5分钟。
8.根据权利要求4所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,所述继续熬制时温度为80-100摄氏度。
9.根据权利要求4所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,所述冷却至60-70摄氏度。
10.根据权利要求4所述的一种治疗跌打损伤的中药组合物的制备方法,其特征在于,所述成品为黑色膏药剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110831917.6A CN113318180A (zh) | 2021-07-22 | 2021-07-22 | 一种治疗跌打损伤的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110831917.6A CN113318180A (zh) | 2021-07-22 | 2021-07-22 | 一种治疗跌打损伤的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113318180A true CN113318180A (zh) | 2021-08-31 |
Family
ID=77426811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110831917.6A Pending CN113318180A (zh) | 2021-07-22 | 2021-07-22 | 一种治疗跌打损伤的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113318180A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115969925A (zh) * | 2023-02-14 | 2023-04-18 | 郸城新东方骨科医院 | 一种活血化瘀、消肿止痛的外用黑膏药、制备及使用方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744961A (zh) * | 2008-12-08 | 2010-06-23 | 徐泽三 | 川芎追风活血膏及其制备方法 |
CN105125797A (zh) * | 2015-09-25 | 2015-12-09 | 林爱云 | 一种治疗风湿痹证以及颈椎、腰椎病的熏蒸外用药液 |
CN107468850A (zh) * | 2017-10-17 | 2017-12-15 | 贵州康珠药业有限公司 | 中药组合物、制备方法及其应用与中药制剂及其制备方法 |
-
2021
- 2021-07-22 CN CN202110831917.6A patent/CN113318180A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744961A (zh) * | 2008-12-08 | 2010-06-23 | 徐泽三 | 川芎追风活血膏及其制备方法 |
CN105125797A (zh) * | 2015-09-25 | 2015-12-09 | 林爱云 | 一种治疗风湿痹证以及颈椎、腰椎病的熏蒸外用药液 |
CN107468850A (zh) * | 2017-10-17 | 2017-12-15 | 贵州康珠药业有限公司 | 中药组合物、制备方法及其应用与中药制剂及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115969925A (zh) * | 2023-02-14 | 2023-04-18 | 郸城新东方骨科医院 | 一种活血化瘀、消肿止痛的外用黑膏药、制备及使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169928B (zh) | 治疗痛经的外用中药组合物及其制备方法和应用 | |
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN100402081C (zh) | 治疗妇科疾病的中成药及其制备方法 | |
CN113318180A (zh) | 一种治疗跌打损伤的中药组合物及其制备方法 | |
CN117064974B (zh) | 一种用于膝骨关节炎消肿镇痛的中药组合物、中药贴膏及其制备方法 | |
CN102218127B (zh) | 治疗痛经的中药组合物及其制备方法 | |
CN102008576B (zh) | 一种治疗扭伤的外用中药及其制备方法 | |
KR101600751B1 (ko) | 녹용을 함유하는 여성 불임증 치료용 한약 조성물 제조 방법 | |
CN105395842A (zh) | 一种用于治疗糖尿病的中药组合物、口服制剂及其制备方法 | |
CN101647901B (zh) | 治疗妇女产后之气血亏虚症的口服中药制剂及其生产方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN110538308B (zh) | 一种生发的中药组合物及其制备方法 | |
CN106668782A (zh) | 一种治疗膝骨关节炎的中药外用制剂及其制备方法 | |
CN105031380A (zh) | 一种用于孕妇口腔局部麻醉的药物及其制备方法 | |
CN111991527A (zh) | 足药浴配方及其制备工艺 | |
CN104983886A (zh) | 治疗便秘的中药制剂及制备方法 | |
CN119405765B (zh) | 一种暖宫中药组合物、含其的暖宫穴位贴及制备方法 | |
CN104623414A (zh) | 一种治疗营养性肥胖的中药组合物 | |
CN111084842B (zh) | 治疗肩周炎、颈椎病、腰椎间盘突出、骨性关节炎的外用中药组合物 | |
CN102475875A (zh) | 一种外用中药制剂及其生产方法 | |
CN114010745A (zh) | 治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 | |
CN105412392A (zh) | 一种治疗痔疮的中药组合物及其制备方法 | |
CN106266548A (zh) | 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 | |
CN105770617A (zh) | 一种药物组合物在制备治疗痔疮药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210831 |
|
RJ01 | Rejection of invention patent application after publication |